This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Janssen Pharmaceutica Nv, Protagonist Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,101 
1 out of 35 
Years Active: 2024
Title: Felix Lai - Innovator in Autoimmune Treatment
Introduction
Felix Lai is a notable inventor based in Newark, CA (US). He has made significant contributions to the field of autoimmune treatment through his innovative research and development.
Latest Patents
Felix Lai holds 1 patent for his invention titled "Compositions of peptide inhibitors of Interleukin-23 receptor." This invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof. It also includes corresponding pharmaceutical compositions, methods, and uses for the treatment of autoimmune inflammation and related diseases and disorders.
Career Highlights
Throughout his career, Felix has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Protagonist Therapeutics, Inc. His work has focused on developing innovative solutions for complex medical challenges.
Collaborations
Felix has collaborated with talented professionals in his field, including Giustino Di Pretoro and Dajun Sun. These collaborations have further enhanced his research and development efforts.
Conclusion
Felix Lai's contributions to the field of autoimmune treatment through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile